Wednesday, 18 January 2012

Drug-Eluting Stent for diabetic patients...

Stent implantation is now a common and highly effective treatment for restoring blood flow through an artery; however the re-narrowing of the diseased artery can occur in a significant proportion of patients.

Although drug-eluting stents have been developed to limit this re-narrowing they have limited effectiveness in diabetic patients. In addition, the drugs that are used inhibit regrowth of the endothelium which is required to protect the artery. Clearly then there is a need for an improved drug-eluting stent that will be suitable for diabetic patients and which will not harm the endothelium.

Using an in vivo model, researchers at the University of Strathclyde have found that restenosis can be prevented by a novel, proprietary compound with no harmful effects on endothelial properties. VAN 10-4, a novel small molecule, exerts a marked protection against the development of restenosis when applied as a drug-eluting stent or given as a short-term local infusion.The researchers believe that the use of VAN 10-4 on a drug-eluting stent holds great promise as a superior stent for high risk patients. Good news for those with diabetes and many others.